Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 4
Submit an article Journal homepage
78
Views
14
CrossRef citations to date
0
Altmetric
Brief Report

Phase I/II Clinical Study of Topotecan and Cytarabine in Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Martin R Weihrauch Department of Internal Medicine I, University of Cologne, GermanyCorrespondence[email protected]
,
Peter Staib Department of Internal Medicine, Klinikum Ludwigshafen, Germany
,
Bettina Seiberlich Practice for Hematology and Oncology, Frankfurt, Germany
,
Martin Hoffmann Department of Internal Medicine I, University of Cologne, Germany
,
Volker Diehl Department of Internal Medicine, Klinikum Ludwigshafen, Germany
&
Hans Tesch Practice for Hematology and Oncology, Frankfurt, Germany
Pages 699-704 | Received 16 Jun 2003, Published online: 03 Aug 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Camilla Stapnes, Bjørn Tore Gjertsen, Håkon Reikvam & Øystein Bruserud. (2009) Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opinion on Investigational Drugs 18:4, pages 433-455.
Read now

Articles from other publishers (13)

Clemence Marcault, Geoffroy Venton, Lauris Gastaud, Lionel Mannone, Jerome Rey, Evelyne D’Incan, Colombe Saillard, Aude Charbonnier, Sophie Raynaud, Norbert Vey & Thomas Cluzeau. (2020) Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines. Clinical Lymphoma Myeloma and Leukemia 20:2, pages e76-e81.
Crossref
Faris Matanes, Basel M.A. AbdelAzeem, Gaurav Shah, Vishnu Reddy, Ayman Saad & Nikolaos Papadantonakis. (2019) Chronic myelomonocytic leukemia associated with myeloid sarcomas and NPM1 mutation: a case report and literature review . Therapeutic Advances in Hematology 10, pages 204062071985459.
Crossref
Ali N. Chamseddine, Elias Jabbour, Hagop M. Kantarjian, Zachary S. Bohannan & Guillermo Garcia-Manero. (2015) Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions. Current Oncology Reports 18:1.
Crossref
Eric Padron. (2015) Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?. Hematology 2015:1, pages 349-354.
Crossref
Christopher B. Benton, Aziz Nazha, Naveen Pemmaraju & Guillermo Garcia-Manero. (2015) Chronic myelomonocytic leukemia: Forefront of the field in 2015. Critical Reviews in Oncology/Hematology 95:2, pages 222-242.
Crossref
Olatoyosi OdenikeFrancesco OnidaEric Padron. (2015) Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms: An Update on Risk Stratification, Molecular Genetics, and Therapeutic Approaches Including Allogeneic Hematopoietic Stem Cell Transplantation. American Society of Clinical Oncology Educational Book:35, pages e398-e412.
Crossref
Eric Padron & David P. Steensma. (2015) Cutting the cord from myelodysplastic syndromes. Current Opinion in Hematology 22:2, pages 163-170.
Crossref
Timothy S. PardeeEvan GomesJamie Jennings-Gee, David Caudell & William H. Gmeiner. (2012) Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity. Blood 119:15, pages 3561-3570.
Crossref
Wei Liu, Yuan-Shan Zhu, Meng Guo, Yun Yu & Guo-Qiang Chen. (2007) Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia. Leukemia Research 31:11, pages 1565-1574.
Crossref
Stefania Laurent, Giulio L. Palmisano, Alberto M. Martelli, Tomohiro Kato, Pier Luigi Tazzari, Ivana Pierri, Marino Clavio, Beatrice Dozin, Giuseppe Balbi, Mauro Megna, Anna Morabito, Teresa Lamparelli, Andrea Bacigalupo, Marco Gobbi & Maria Pia Pistillo. (2007) CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis. British Journal of Haematology 136:4, pages 597-608.
Crossref
Karen J. Haglof, Elizabeta Popa & Howard S. Hochster. (2006) Recent developments in the clinical activity of topoisomerase-1 inhibitors. Update on Cancer Therapeutics 1:2, pages 117-145.
Crossref
Man-Gen SongShen-Meng GaoKe-Ming DuMin XuYun YuYu-Hong ZhouQiong WangZhu ChenYuan-Shan ZhuGuo-Qiang Chen. (2005) Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cδ–dependent mechanisms. Blood 105:9, pages 3714-3721.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.